Cargando…
84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA
ABSTRACT IMPACT: Summarize the burden of diabetes comorbidities and its impact in healthcare utilization in Puerto Rico OBJECTIVES/GOALS: To estimate the prevalence of common comorbidities and describe the healthcare utilization patterns in patients with type 2 diabetes mellitus (T2DM) in Puerto Ric...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827741/ http://dx.doi.org/10.1017/cts.2021.488 |
_version_ | 1784647700646461440 |
---|---|
author | Garcia-Rivera, Enid Ruiz, Krystel Miranda, Edgar Mejã, Luis Marques, Cecile Quijada, José Monsanto, Homero Orengo, Juan Pinzón, Adolfo |
author_facet | Garcia-Rivera, Enid Ruiz, Krystel Miranda, Edgar Mejã, Luis Marques, Cecile Quijada, José Monsanto, Homero Orengo, Juan Pinzón, Adolfo |
author_sort | Garcia-Rivera, Enid |
collection | PubMed |
description | ABSTRACT IMPACT: Summarize the burden of diabetes comorbidities and its impact in healthcare utilization in Puerto Rico OBJECTIVES/GOALS: To estimate the prevalence of common comorbidities and describe the healthcare utilization patterns in patients with type 2 diabetes mellitus (T2DM) in Puerto Rico. METHODS/STUDY POPULATION: This is a descriptive study using healthcare claims data from patients with T2DM (based on ICD-9 diagnosis code) from most public and private healthcare insurance companies providing services in Puerto Rico in 2013 (representing more than 90% of insured population). Descriptive analyses by age, sex, type of insurance, health region, and type of medical encounter were done using frequency and percent for categorical data or means or median (with corresponding standard deviation or interquartile range) for continuous variables RESULTS/ANTICIPATED RESULTS: A total of 3,100,636 claims were identified from 485,866 adult patients with T2DM. Most patients were women (276,400; 57%), older than 65 years (235,390; 48%), from the Puerto Rico health regions of Caguas (79,604; 16%), Metro (66,280; 14%), or Bayamon (62,673; 13%) with private health insurance (371,806; 77%). The number of claims per patient ranged from 1 to 339. A mean of 6.3 claims (SD ±9.99) and a median of 3 claims (Q1 1- Q3 8) per subject were identified. Most (74%) were related to the diagnosis of diabetes (1,829,2015; 59%) or to cardiovascular diseases (458,219; 15%) and associated to outpatient services (2,722,727; 88%). The most prevalent comorbidities were hypertension (235,277; 48%), hyperlipidemia (197,449; 41%), neuropathy (100,471; 21%); renal disease (71,517; 15%), and retinopathy (61,837; 13%) DISCUSSION/SIGNIFICANCE OF FINDINGS: A high prevalence of comorbidities and use of healthcare services were identified in patients with T2DM, especially in older adults. Most comorbidities were due to diabetes-related conditions, highlighting the importance of early diagnosis and adequate management of T2DM patients to avoid preventable burden to the patient and the healthcare system |
format | Online Article Text |
id | pubmed-8827741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88277412022-02-28 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA Garcia-Rivera, Enid Ruiz, Krystel Miranda, Edgar Mejã, Luis Marques, Cecile Quijada, José Monsanto, Homero Orengo, Juan Pinzón, Adolfo J Clin Transl Sci Clinical Epidemiology ABSTRACT IMPACT: Summarize the burden of diabetes comorbidities and its impact in healthcare utilization in Puerto Rico OBJECTIVES/GOALS: To estimate the prevalence of common comorbidities and describe the healthcare utilization patterns in patients with type 2 diabetes mellitus (T2DM) in Puerto Rico. METHODS/STUDY POPULATION: This is a descriptive study using healthcare claims data from patients with T2DM (based on ICD-9 diagnosis code) from most public and private healthcare insurance companies providing services in Puerto Rico in 2013 (representing more than 90% of insured population). Descriptive analyses by age, sex, type of insurance, health region, and type of medical encounter were done using frequency and percent for categorical data or means or median (with corresponding standard deviation or interquartile range) for continuous variables RESULTS/ANTICIPATED RESULTS: A total of 3,100,636 claims were identified from 485,866 adult patients with T2DM. Most patients were women (276,400; 57%), older than 65 years (235,390; 48%), from the Puerto Rico health regions of Caguas (79,604; 16%), Metro (66,280; 14%), or Bayamon (62,673; 13%) with private health insurance (371,806; 77%). The number of claims per patient ranged from 1 to 339. A mean of 6.3 claims (SD ±9.99) and a median of 3 claims (Q1 1- Q3 8) per subject were identified. Most (74%) were related to the diagnosis of diabetes (1,829,2015; 59%) or to cardiovascular diseases (458,219; 15%) and associated to outpatient services (2,722,727; 88%). The most prevalent comorbidities were hypertension (235,277; 48%), hyperlipidemia (197,449; 41%), neuropathy (100,471; 21%); renal disease (71,517; 15%), and retinopathy (61,837; 13%) DISCUSSION/SIGNIFICANCE OF FINDINGS: A high prevalence of comorbidities and use of healthcare services were identified in patients with T2DM, especially in older adults. Most comorbidities were due to diabetes-related conditions, highlighting the importance of early diagnosis and adequate management of T2DM patients to avoid preventable burden to the patient and the healthcare system Cambridge University Press 2021-03-30 /pmc/articles/PMC8827741/ http://dx.doi.org/10.1017/cts.2021.488 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Epidemiology Garcia-Rivera, Enid Ruiz, Krystel Miranda, Edgar Mejã, Luis Marques, Cecile Quijada, José Monsanto, Homero Orengo, Juan Pinzón, Adolfo 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA |
title | 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA |
title_full | 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA |
title_fullStr | 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA |
title_full_unstemmed | 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA |
title_short | 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA |
title_sort | 84617 prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus living in puerto rico, usa |
topic | Clinical Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827741/ http://dx.doi.org/10.1017/cts.2021.488 |
work_keys_str_mv | AT garciariveraenid 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT ruizkrystel 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT mirandaedgar 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT mejaluis 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT marquescecile 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT quijadajose 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT monsantohomero 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT orengojuan 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa AT pinzonadolfo 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa |